We are live on ! Find out more
NXTC icon

NextCure
NXTC

83 hedge funds and large institutions have $158M invested in NextCure in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $2.59M | Put options by funds: $1.38M

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

11% more funds holding

Funds holding: 75 → 83 (+8)

1% more capital invested

Capital invested by funds: $156M → $158M (+$2.1M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.13% less ownership

Funds ownership: 5.52% → 4.4% (-1.1%)

24% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 29

Holders
83
Holders Change
+8
Holders Change %
+10.67%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
22
Reduced
29
Closed
12
Calls
$2.59M
Puts
$1.38M
Net Calls
+$1.21M
Net Calls Change
+$578K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$12M
2
LPC
Lion Point Capital
New York
+$3.23M
3
BlackRock
BlackRock
New York
+$3.08M
4
MWNA
Marshall Wace North America
New York
+$1.05M
5
Goldman Sachs
Goldman Sachs
New York
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
-$23.5M
2
CPX
Canaan Partners X
California
-$9.4M
3
Deutsche Bank
Deutsche Bank
Germany
-$5.26M
4
Millennium Management
Millennium Management
New York
-$4.38M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$29.6M – – –
Morgan Stanley
2
Morgan Stanley
New York
$23.8M +$12M +92,769 +104%
BlackRock
3
BlackRock
New York
$16.5M +$3.08M +23,821 +23%
Citadel Advisors
4
Citadel Advisors
Florida
$11.7M -$34.6K -268 -0.3%
CPX
5
Canaan Partners X
California
$9.14M -$9.4M -72,756 -51%
Vanguard Group
6
Vanguard Group
Pennsylvania
$7.95M +$448K +3,467 +6%
ACH
7
ArrowMark Colorado Holdings
Colorado
$7.82M -$62.8K -486 -0.8%
HA
8
HHLR Advisors
Cayman Islands
$6.96M – – –
VOYA Investment Management
9
VOYA Investment Management
Georgia
$5.72M -$514K -3,978 -8%
LPC
10
Lion Point Capital
New York
$3.27M +$3.23M +25,000 New
State Street
11
State Street
Massachusetts
$2.93M -$147K -1,134 -5%
Goldman Sachs
12
Goldman Sachs
New York
$2.54M +$1.03M +7,982 +70%
Northern Trust
13
Northern Trust
Illinois
$2.24M -$54.3K -420 -2%
IC
14
Ikarian Capital
Texas
$2.18M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.04M -$156K -1,211 -7%
MWNA
16
Marshall Wace North America
New York
$1.85M +$1.05M +8,125 +135%
Macquarie Group
17
Macquarie Group
Australia
$1.64M +$538K +4,166 +50%
SCM
18
Silverarc Capital Management
Massachusetts
$1.42M +$1.4M +10,833 New
Man Group
19
Man Group
United Kingdom
$1.23M -$97.7K -756 -7%
Charles Schwab
20
Charles Schwab
California
$1.05M +$78K +604 +8%
PP
21
PDT Partners
New York
$1.02M -$1.44M -11,146 -59%
Millennium Management
22
Millennium Management
New York
$956K -$4.38M -33,909 -82%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$932K -$945K -7,317 -51%
Nomura Holdings
24
Nomura Holdings
Japan
$840K +$827K +6,400 New
DCM
25
DAFNA Capital Management
California
$709K -$215K -1,666 -24%
1
2 3 4

NXTC Hedge Fund Activity: Q4 2020 in Review

83 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2020, worth a combined $158M — up 1.3% from $156M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new NXTC positions and 12 closed out — a net gain of 8 holders — while 22 added to existing stakes and 29 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $12M. The largest seller was Sofinnova Investments, exiting entirely with an estimated $23.5M sold.

  • 83 institutional investors held NextCure (NXTC) as of Q4 2020, up from 75 in Q3 2020.
  • Funds reported $158M of NextCure stock for Q4 2020, up 1.3% quarter-over-quarter.
  • 20 funds opened new NextCure positions in Q4 2020 and 12 closed out, a net change of +8 holders.
  • The largest NextCure buyer in Q4 2020 was Morgan Stanley, an estimated $12M added.
  • The largest NextCure seller in Q4 2020 was Sofinnova Investments, an estimated $23.5M sold.

Based on aggregated 13F filings for Q4 2020.